| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.06e-04 | 14 | 136 | 3 | GO:0008331 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A CACNA1B FLNA PSD2 PDE9A ENPP1 HNRNPAB HNRNPK IL1RAPL1 TTBK1 NF1 NDEL1 CLCN2 SHANK2 ZPR1 CACNA1G PRKCZ DMD GOLGA8A DCP1A | 1.34e-04 | 1228 | 136 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | FLNA ERCC6 SETD1B IPO7 BACH2 GPATCH1 NOL6 INTS1 NSD1 GON4L CHMP4BP1 CHD4 WRAP53 HNRNPAB HNRNPK POLR3A BAZ2A ASXL3 SMARCC2 IK MED12 | 2.23e-04 | 1377 | 136 | 21 | GO:0140513 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1A CACNA1B FLNA PSD2 PDE9A ENPP1 TTBK1 NDEL1 CLCN2 SHANK2 ZPR1 CACNA1G PRKCZ DMD GOLGA8A | 3.58e-04 | 835 | 136 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | CACNA1A CACNA1B FLNA PSD2 PDE9A PODXL ENPP1 TTBK1 NDEL1 CLCN2 SHANK2 ZPR1 CACNA1G PRKCZ DMD GOLGA8A | 3.60e-04 | 929 | 136 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 4.12e-04 | 96 | 136 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | GARP complex | 4.15e-04 | 5 | 136 | 2 | GO:0000938 | |
| GeneOntologyCellularComponent | EARP complex | 4.15e-04 | 5 | 136 | 2 | GO:1990745 | |
| HumanPheno | Abnormality of cranial sutures | FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 HNRNPK POLR3A SH3PXD2B ARVCF RTL1 ASXL3 PRKCZ MED12 | 3.28e-06 | 388 | 45 | 14 | HP:0011329 |
| HumanPheno | Scoliosis | FKBP10 FLNA ERCC6 PODXL ENPP1 INTS1 NSD1 WRAP53 PRDM5 CBS HNRNPK POLR3A SH3PXD2B NF1 ARVCF RTL1 ASXL3 SMARCC2 CACNA1G PRKCZ DMD VPS53 MED12 | 1.62e-05 | 1122 | 45 | 23 | HP:0002650 |
| HumanPheno | Abnormal curvature of the vertebral column | FKBP10 FLNA ERCC6 PODXL ENPP1 INTS1 NSD1 WRAP53 PRDM5 CBS HNRNPK POLR3A SHROOM4 SH3PXD2B NF1 ARVCF RTL1 ASXL3 SMARCC2 CACNA1G PRKCZ DMD VPS53 MED12 | 1.84e-05 | 1219 | 45 | 24 | HP:0010674 |
| HumanPheno | Abnormal male reproductive system physiology | FLNA ERCC6 DPY19L2 PODXL NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ SPAG17 MED12 | 1.95e-05 | 1314 | 45 | 25 | HP:0012874 |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 HNRNPK POLR3A SH3PXD2B ARVCF RTL1 ASXL3 PRKCZ MED12 | 3.19e-05 | 472 | 45 | 14 | HP:0000235 |
| HumanPheno | Abnormal spermatogenesis | FLNA ERCC6 DPY19L2 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 4.46e-05 | 1190 | 45 | 23 | HP:0008669 |
| HumanPheno | Abnormal aortic morphology | FLNA ERCC6 ENPP1 NSD1 CHD4 HNRNPK NF1 ARVCF RTL1 PRKCZ TNNT2 MED12 | 4.77e-05 | 363 | 45 | 12 | HP:0030963 |
| HumanPheno | Abnormal testis morphology | FLNA ERCC6 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 6.63e-05 | 1129 | 45 | 22 | HP:0000035 |
| HumanPheno | Non-obstructive azoospermia | FLNA ERCC6 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 6.92e-05 | 1132 | 45 | 22 | HP:0011961 |
| HumanPheno | Hydronephrosis | 7.49e-05 | 264 | 45 | 10 | HP:0000126 | |
| HumanPheno | Vascular dilatation | 8.45e-05 | 215 | 45 | 9 | HP:0002617 | |
| HumanPheno | Abnormal male external genitalia morphology | FLNA BNC2 ERCC6 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ SPAG17 MED12 | 8.50e-05 | 1329 | 45 | 24 | HP:0000032 |
| HumanPheno | Mitral valve prolapse | 8.54e-05 | 123 | 45 | 7 | HP:0001634 | |
| HumanPheno | Hirsutism | 8.76e-05 | 216 | 45 | 9 | HP:0001007 | |
| HumanPheno | Long toe | 9.00e-05 | 168 | 45 | 8 | HP:0010511 | |
| HumanPheno | Abnormal male internal genitalia morphology | FLNA ERCC6 DPY19L2 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 9.25e-05 | 1243 | 45 | 23 | HP:0000022 |
| HumanPheno | Long foot | 9.32e-05 | 28 | 45 | 4 | HP:0001833 | |
| HumanPheno | Azoospermia | FLNA ERCC6 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 9.81e-05 | 1157 | 45 | 22 | HP:0000027 |
| HumanPheno | Abnormality of the male genitalia | FLNA BNC2 ERCC6 DPY19L2 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ SPAG17 MED12 | 1.00e-04 | 1437 | 45 | 25 | HP:0010461 |
| HumanPheno | Foot joint contracture | FKBP10 FLNA ERCC6 NSD1 POLR3A SH3PXD2B RTL1 ASXL3 PRKCZ DMD MED12 | 1.10e-04 | 334 | 45 | 11 | HP:0008366 |
| HumanPheno | Abnormal aortic morphology | FLNA ERCC6 ENPP1 NSD1 CHD4 HNRNPK NF1 ARVCF RTL1 PRKCZ TNNT2 MED12 | 1.26e-04 | 401 | 45 | 12 | HP:0001679 |
| HumanPheno | Functional abnormality of male internal genitalia | FLNA ERCC6 DPY19L2 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ SPAG17 MED12 | 1.30e-04 | 1269 | 45 | 23 | HP:0000025 |
| HumanPheno | Abnormal external genitalia | FLNA BNC2 ERCC6 NSD1 CHD4 USP9Y WRAP53 PRDM5 CBS HNRNPK STT3B POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ SPAG17 MED12 | 1.47e-04 | 1372 | 45 | 24 | HP:0000811 |
| HumanPheno | Dilatation of the renal pelvis | 1.65e-04 | 290 | 45 | 10 | HP:0010946 | |
| HumanPheno | Wormian bones | 1.76e-04 | 61 | 45 | 5 | HP:0002645 | |
| HumanPheno | Abnormality of lower limb joint | FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 PRDM5 CBS HNRNPK POLR3A SHROOM4 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 PRKCZ DMD MED12 | 1.84e-04 | 1027 | 45 | 20 | HP:0100491 |
| HumanPheno | Flexion contracture of finger | 1.97e-04 | 240 | 45 | 9 | HP:0005651 | |
| HumanPheno | Interphalangeal joint contracture of finger | 1.97e-04 | 240 | 45 | 9 | HP:0001220 | |
| HumanPheno | Flexion contracture of toe | 1.97e-04 | 240 | 45 | 9 | HP:0005830 | |
| HumanPheno | Camptodactyly (hands) | 1.97e-04 | 240 | 45 | 9 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 1.97e-04 | 240 | 45 | 9 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 1.97e-04 | 240 | 45 | 9 | HP:0100490 | |
| HumanPheno | Camptodactyly of toe | 1.97e-04 | 240 | 45 | 9 | HP:0001836 | |
| HumanPheno | Toe joint contracture | 2.03e-04 | 241 | 45 | 9 | HP:0034675 | |
| HumanPheno | Abnormal renal pelvis morphology | 2.18e-04 | 300 | 45 | 10 | HP:0010944 | |
| HumanPheno | Upper-limb joint contracture | FKBP10 FLNA ERCC6 NSD1 POLR3A SH3PXD2B RTL1 ASXL3 PRKCZ DMD MED12 | 2.25e-04 | 362 | 45 | 11 | HP:0100360 |
| HumanPheno | Abnormal eyelid morphology | CACNA1A CACNA1B FLNA ERCC6 SETD1B INTS1 NSD1 CHD4 WRAP53 HNRNPK POLR3A SHROOM4 IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ VPS53 MED12 | 2.27e-04 | 1408 | 45 | 24 | HP:0000492 |
| HumanPheno | Left axis deviation | 2.28e-04 | 3 | 45 | 2 | HP:0033568 | |
| HumanPheno | Long phalanx of finger | 2.28e-04 | 3 | 45 | 2 | HP:0006155 | |
| HumanPheno | Abnormal knee morphology | 2.37e-04 | 364 | 45 | 11 | HP:0034669 | |
| HumanPheno | Abnormal delivery | 2.40e-04 | 145 | 45 | 7 | HP:0001787 | |
| HumanPheno | Abnormal mitral valve morphology | 2.50e-04 | 146 | 45 | 7 | HP:0031477 | |
| HumanPheno | Abnormality of the palpebral fissures | CACNA1A CACNA1B FLNA ERCC6 SETD1B INTS1 NSD1 CHD4 HNRNPK POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 CACNA1G MED12 | 2.52e-04 | 880 | 45 | 18 | HP:0008050 |
| HumanPheno | Kyphoscoliosis | 2.63e-04 | 196 | 45 | 8 | HP:0002751 | |
| HumanPheno | Flexion contracture of finger | 3.29e-04 | 257 | 45 | 9 | HP:0012785 | |
| HumanPheno | Bowing of the long bones | 3.32e-04 | 316 | 45 | 10 | HP:0006487 | |
| HumanPheno | Finger joint contracture | 3.49e-04 | 259 | 45 | 9 | HP:0034681 | |
| HumanPheno | Sparse hair | FLNA ERCC6 NSD1 WRAP53 CBS POLR3A NF1 ASXL3 SMARCC2 CACNA1G MED12 | 3.69e-04 | 383 | 45 | 11 | HP:0008070 |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 3.80e-04 | 262 | 45 | 9 | HP:0006261 | |
| HumanPheno | Anomaly of the limb diaphyses | 3.87e-04 | 322 | 45 | 10 | HP:0006504 | |
| HumanPheno | Abnormal joint physiology | CACNA1A FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 PRDM5 CBS HNRNPK POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ DMD VPS53 MED12 | 3.88e-04 | 1358 | 45 | 23 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | CACNA1A FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 PRDM5 CBS HNRNPK POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 PRKCZ DMD VPS53 MED12 | 3.88e-04 | 1358 | 45 | 23 | HP:0011729 |
| HumanPheno | Functional abnormality of the middle ear | CACNA1A CACNA1B FLNA ERCC6 ENPP1 NSD1 PRDM5 HNRNPK NF1 ARVCF PRKCZ | 3.95e-04 | 386 | 45 | 11 | HP:0011452 |
| HumanPheno | Deeply set eye | 4.25e-04 | 266 | 45 | 9 | HP:0000490 | |
| HumanPheno | Abnormal femoral neck morphology | 4.39e-04 | 160 | 45 | 7 | HP:0003367 | |
| HumanPheno | Anterior concavity of thoracic vertebrae | 4.53e-04 | 4 | 45 | 2 | HP:0004611 | |
| HumanPheno | Coat hanger sign of ribs | 4.53e-04 | 4 | 45 | 2 | HP:0006665 | |
| HumanPheno | Telangiectasia | 4.56e-04 | 161 | 45 | 7 | HP:0001009 | |
| HumanPheno | Abnormality of hair density | FLNA ERCC6 NSD1 WRAP53 CBS POLR3A NF1 ASXL3 SMARCC2 CACNA1G MED12 | 5.14e-04 | 398 | 45 | 11 | HP:0011357 |
| HumanPheno | Lower-limb joint contracture | FKBP10 FLNA ERCC6 NSD1 POLR3A SH3PXD2B RTL1 ASXL3 PRKCZ DMD MED12 | 5.72e-04 | 403 | 45 | 11 | HP:0005750 |
| HumanPheno | Aortic dilatation | 5.90e-04 | 168 | 45 | 7 | HP:0001724 | |
| HumanPheno | Aortic aneurysm | 5.90e-04 | 168 | 45 | 7 | HP:0004942 | |
| HumanPheno | Vesicoureteral reflux | 5.93e-04 | 221 | 45 | 8 | HP:0000076 | |
| HumanPheno | Abnormality of the dentition | CACNA1A CACNA1B FKBP10 FLNA ERCC6 ENPP1 NSD1 WRAP53 PRDM5 CBS HNRNPK POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF ASXL3 SMARCC2 MED12 | 6.12e-04 | 1030 | 45 | 19 | HP:0000164 |
| HumanPheno | Abnormal diaphysis morphology | 6.40e-04 | 343 | 45 | 10 | HP:0000940 | |
| HumanPheno | Abnormality of the chin | FLNA ERCC6 NSD1 POLR3A IL1RAPL1 SH3PXD2B RTL1 ASXL3 CACNA1G PRKCZ MED12 | 6.48e-04 | 409 | 45 | 11 | HP:0000306 |
| HumanPheno | Macroorchidism | 6.61e-04 | 20 | 45 | 3 | HP:0000053 | |
| HumanPheno | Tall stature | 6.69e-04 | 225 | 45 | 8 | HP:0000098 | |
| HumanPheno | Intellectual disability, moderate | 6.79e-04 | 172 | 45 | 7 | HP:0002342 | |
| HumanPheno | Camptodactyly | FLNA ERCC6 NSD1 PRDM5 POLR3A SH3PXD2B RTL1 ASXL3 PRKCZ MED12 | 6.85e-04 | 346 | 45 | 10 | HP:0012385 |
| HumanPheno | Flushing | 7.19e-04 | 47 | 45 | 4 | HP:0031284 | |
| HumanPheno | Abnormality of refraction | FLNA ERCC6 ENPP1 INTS1 NSD1 CHD4 PRDM5 CBS HNRNPK POLR3A ASXL3 SMARCC2 CACNA1G PRKCZ MED12 | 7.30e-04 | 709 | 45 | 15 | HP:0000539 |
| HumanPheno | Joint hypermobility | FKBP10 FLNA ENPP1 NSD1 PRDM5 HNRNPK POLR3A IL1RAPL1 NF1 ARVCF RTL1 SMARCC2 MED12 | 7.40e-04 | 557 | 45 | 13 | HP:0001382 |
| HumanPheno | Abnormal ventricular axis | 7.50e-04 | 5 | 45 | 2 | HP:0033566 | |
| HumanPheno | Abnormal hair morphology | CACNA1A FLNA ERCC6 SETD1B ENPP1 INTS1 NSD1 WRAP53 PRDM5 CBS HNRNPK POLR3A SHROOM4 IL1RAPL1 NF1 ARVCF RTL1 ASXL3 ZPR1 SMARCC2 CACNA1G PRKCZ MED12 | 8.11e-04 | 1424 | 45 | 23 | HP:0001595 |
| HumanPheno | Abnormal hip joint morphology | FKBP10 FLNA ENPP1 NSD1 CHD4 PRDM5 HNRNPK POLR3A SHROOM4 SH3PXD2B PRKCZ MED12 | 8.16e-04 | 490 | 45 | 12 | HP:0001384 |
| HumanPheno | Abnormality of the knee | FKBP10 FLNA ERCC6 ENPP1 NSD1 CBS POLR3A SH3PXD2B NF1 ARVCF ZPR1 DMD | 8.31e-04 | 491 | 45 | 12 | HP:0002815 |
| HumanPheno | Joint contractures | 8.39e-04 | 292 | 45 | 9 | HP:0001372 | |
| HumanPheno | Abnormally lax or hyperextensible skin | 8.61e-04 | 179 | 45 | 7 | HP:0008067 | |
| HumanPheno | Abnormality of mouth shape | 8.82e-04 | 294 | 45 | 9 | HP:0011338 | |
| HumanPheno | Joint contracture of the hand | 9.26e-04 | 296 | 45 | 9 | HP:0009473 | |
| HumanPheno | Downslanted palpebral fissures | CACNA1A CACNA1B FLNA SETD1B NSD1 HNRNPK POLR3A SH3PXD2B NF1 ARVCF ASXL3 MED12 | 9.26e-04 | 497 | 45 | 12 | HP:0000494 |
| HumanPheno | Flexion contracture of digit | FLNA ERCC6 NSD1 PRDM5 POLR3A SH3PXD2B RTL1 ASXL3 PRKCZ MED12 | 9.76e-04 | 362 | 45 | 10 | HP:0030044 |
| HumanPheno | Arachnodactyly | 9.98e-04 | 133 | 45 | 6 | HP:0001166 | |
| HumanPheno | Restrictive cardiomyopathy | 1.01e-03 | 23 | 45 | 3 | HP:0001723 | |
| HumanPheno | Abnormal hip bone morphology | FKBP10 FLNA ERCC6 ENPP1 NSD1 CHD4 PRDM5 HNRNPK POLR3A SHROOM4 SH3PXD2B RTL1 PRKCZ MED12 | 1.03e-03 | 653 | 45 | 14 | HP:0003272 |
| HumanPheno | Abnormal synovial membrane morphology | FKBP10 FLNA ENPP1 NSD1 CHD4 PRDM5 HNRNPK POLR3A SHROOM4 SH3PXD2B PRKCZ MED12 | 1.03e-03 | 503 | 45 | 12 | HP:0005262 |
| HumanPheno | Intellectual disability, mild | 1.04e-03 | 365 | 45 | 10 | HP:0001256 | |
| HumanPheno | Delayed eruption of teeth | 1.05e-03 | 185 | 45 | 7 | HP:0000684 | |
| HumanPheno | Flexion contracture | CACNA1A FKBP10 FLNA ERCC6 ENPP1 NSD1 PRDM5 POLR3A SH3PXD2B RTL1 ASXL3 ZPR1 PRKCZ DMD VPS53 MED12 | 1.08e-03 | 817 | 45 | 16 | HP:0001371 |
| HumanPheno | Coarse facial features | 1.08e-03 | 242 | 45 | 8 | HP:0000280 | |
| HumanPheno | Abnormal morphology of the great vessels | FLNA ERCC6 ENPP1 NSD1 CHD4 TSFM HNRNPK SH3PXD2B NF1 ARVCF RTL1 SMARCC2 PRKCZ TNNT2 MED12 | 1.09e-03 | 736 | 45 | 15 | HP:0030962 |
| HumanPheno | Slanting of the palpebral fissure | CACNA1A CACNA1B FLNA SETD1B NSD1 CHD4 HNRNPK POLR3A IL1RAPL1 SH3PXD2B NF1 ARVCF ASXL3 CACNA1G MED12 | 1.13e-03 | 739 | 45 | 15 | HP:0200006 |
| HumanPheno | Kyphosis | FKBP10 FLNA ERCC6 NSD1 CBS POLR3A SHROOM4 SH3PXD2B NF1 RTL1 PRKCZ DMD | 1.17e-03 | 510 | 45 | 12 | HP:0002808 |
| HumanPheno | Abnormal ureter physiology | 1.17e-03 | 245 | 45 | 8 | HP:0025634 | |
| HumanPheno | Long fingers | 1.17e-03 | 306 | 45 | 9 | HP:0100807 | |
| HumanPheno | Stroke | 1.19e-03 | 189 | 45 | 7 | HP:0001297 | |
| HumanPheno | Coxa valga | 1.19e-03 | 92 | 45 | 5 | HP:0002673 | |
| HumanPheno | Conductive hearing impairment | 1.23e-03 | 373 | 45 | 10 | HP:0000405 | |
| HumanPheno | Hip dysplasia | 1.23e-03 | 247 | 45 | 8 | HP:0001385 | |
| Domain | VDCCAlpha1 | 3.99e-05 | 10 | 132 | 3 | IPR002077 | |
| Domain | CD34_antigen | 1.48e-04 | 3 | 132 | 2 | PF06365 | |
| Domain | CD34/Podocalyxin | 1.48e-04 | 3 | 132 | 2 | IPR013836 | |
| Domain | CBS | 1.81e-04 | 16 | 132 | 3 | SM00116 | |
| Domain | CBS_dom | 3.60e-04 | 20 | 132 | 3 | IPR000644 | |
| Domain | CBS | 3.60e-04 | 20 | 132 | 3 | PF00571 | |
| Domain | CBS | 3.60e-04 | 20 | 132 | 3 | PS51371 | |
| Pubmed | FLNA IPO7 IRF2BP1 PPRC1 PODXL TCEAL4 NOL6 NASP DIDO1 PSMD3 CHD4 HNRNPAB TNFRSF8 ZNF638 CACNA1G DMD TASOR | 8.09e-09 | 754 | 137 | 17 | 35906200 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA AKAP8 DAB2 NASP DIDO1 CHD4 WRAP53 HNRNPK ESYT2 NF1 MDN1 FAM13A BAZ2A ZNF638 SENP6 SMARCC2 DCP1A | 1.19e-08 | 774 | 137 | 17 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA ERCC6 SETD1B IPO7 NOL6 PSMD3 CHD4 HNRNPAB HNRNPK POLR3A NF1 MDN1 FAM120A ARVCF HNRNPUL2 BAZ2A MICAL2 ZNF638 SMARCC2 IK MED12 DCP1A | 1.71e-08 | 1353 | 137 | 22 | 29467282 |
| Pubmed | AKAP8 USP9Y HNRNPAB HNRNPK FAM120A HNRNPUL2 ZNF638 SMARCC2 IK TASOR | 5.05e-08 | 244 | 137 | 10 | 29884807 | |
| Pubmed | FLNA IPO7 NOL6 INTS1 NSD1 DIDO1 CHD4 NF1 MDN1 FAM120A BAZ2A ZNF638 SMARCC2 IK MED12 | 5.09e-08 | 653 | 137 | 15 | 22586326 | |
| Pubmed | AKAP6 FLNA SALL3 GBP7 PPRC1 PEG3 NSD1 NASP DIDO1 HNRNPK SH3PXD2B ZNF638 PRKCZ PEAK1 DOT1L IK TASOR DCP1A RAB11FIP3 | 5.62e-08 | 1084 | 137 | 19 | 11544199 | |
| Pubmed | FLNA ERCC6 AKAP8 POGK DAB2 NASP DIDO1 HNRNPAB HNRNPK FAM120A FAM13A HNRNPUL2 ZNF638 | 1.09e-07 | 503 | 137 | 13 | 16964243 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | GPATCH1 NOL6 INTS1 RNF213 DIDO1 CBS BAZ2A ZNF638 SMARCC2 MED12 DCP1A | 1.21e-07 | 341 | 137 | 11 | 32971831 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNA AKAP8 IPO7 IRF2BP1 NOL6 INTS1 PSMD3 CHD4 HNRNPAB HNRNPK KIAA1671 NF1 MDN1 CCN1 HNRNPUL2 ZNF638 SMARCC2 IK | 1.24e-07 | 1024 | 137 | 18 | 24711643 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | FLNA NOL6 INTS1 DIDO1 CHD4 HNRNPAB HNRNPK ESYT2 ZNF638 SMARCC2 | 1.34e-07 | 271 | 137 | 10 | 32433965 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | FLNA SALL3 GPATCH1 NOL6 NSD1 DIDO1 CHD4 SSX2 HNRNPAB HNRNPK BAZ2A ZNF638 SENP6 SMARCC2 IK TASOR NSMCE4A | 2.37e-07 | 954 | 137 | 17 | 36373674 |
| Pubmed | CACNA1A AKAP8 NSD1 DIDO1 CHD4 JAKMIP3 HNRNPK SH3PXD2B NF1 MDN1 FAM120A SHANK2 ARVCF HNRNPUL2 SMARCC2 GOLGA8A UNC79 | 2.70e-07 | 963 | 137 | 17 | 28671696 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF597 FLNA IPO7 PODXL NOL6 INTS1 RER1 PSMD3 PODXL2 CHD4 HNRNPK STT3B ESYT2 VPS52 MICAL2 SMARCC2 MNT MED12 ZNF646 | 2.79e-07 | 1203 | 137 | 19 | 29180619 |
| Pubmed | FLNA NSD1 NASP DIDO1 HNRNPK KIAA1671 SH3PXD2B BAZ2A PEAK1 DOT1L IK MED12 DCP1A | 2.95e-07 | 549 | 137 | 13 | 38280479 | |
| Pubmed | POGK ENPP1 NOL6 RER1 GON4L DIDO1 POLR3A FAM120A ARVCF HNRNPUL2 ZNF638 CDC25B TASOR CRTC2 | 3.17e-07 | 650 | 137 | 14 | 38777146 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 AKAP8 NOL6 DIDO1 PSMD3 CHD4 HNRNPAB HNRNPK MDN1 FAM120A HNRNPUL2 IK TASOR MED12 NSMCE4A | 3.50e-07 | 759 | 137 | 15 | 35915203 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FLNA PDE9A EFS GPATCH1 NASP CBS HNRNPK NF1 FAM13A SMARCC2 GCC1 IK MAPK7 | 3.69e-07 | 560 | 137 | 13 | 21653829 |
| Pubmed | ERCC6 AKAP8 PPP1R12B NOL6 INTS1 NSD1 GON4L DIDO1 WRAP53 ZBTB7B STT3B KIAA1671 ESYT2 MDN1 SHANK2 BAZ2A PALM3 TMED2 IK TASOR MED12 | 4.35e-07 | 1497 | 137 | 21 | 31527615 | |
| Pubmed | FLNA AKAP8 IPO7 INTS1 RNF213 PSMD3 CHD4 HNRNPK STT3B POLR3A ESYT2 NF1 MDN1 AGO4 FAM120A HNRNPUL2 MED12 DCP1A | 8.40e-07 | 1168 | 137 | 18 | 19946888 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 8.90e-07 | 130 | 137 | 7 | 35545047 | |
| Pubmed | FLNA AKAP8 IPO7 IRF2BP1 NOL6 DAB2 RNF213 PSMD3 CHD4 HNRNPAB STT3B POLR3A KIAA1671 ESYT2 MDN1 FAM120A HNRNPUL2 TMED2 VPS53 DCP1A | 9.86e-07 | 1440 | 137 | 20 | 30833792 | |
| Pubmed | FLNA TTC16 PPRC1 PPP1R12B NOL6 PSMD3 CHD4 HNRNPAB STT3B MDN1 SHANK2 ZBED4 SNX25 FAM169A SMARCC2 DMD MAPK6 SPAG17 TASOR NSMCE4A | 1.01e-06 | 1442 | 137 | 20 | 35575683 | |
| Pubmed | FLNA ZFAT SETD1B INTS1 NASP RER1 HNRNPK STT3B VPS52 NF1 ZBED4 PRKAB1 VSIG10L FAM169A TMED2 MAPK6 MNT MED12 RAB11FIP3 | 1.21e-06 | 1327 | 137 | 19 | 32694731 | |
| Pubmed | 2.36e-06 | 215 | 137 | 8 | 35973513 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNA ERCC6 AKAP8 IPO7 NOL6 RER1 DIDO1 PSMD3 HNRNPAB HNRNPK STT3B AFAP1L1 KIAA1671 FAM120A CCN1 HNRNPUL2 ZNF638 IK | 2.37e-06 | 1257 | 137 | 18 | 36526897 |
| Pubmed | AKAP8 PODXL GPATCH1 NOL6 RNF213 PODXL2 CHD4 HNRNPK KIAA1671 VPS52 ZNF638 GCC1 PEAK1 TASOR | 2.58e-06 | 777 | 137 | 14 | 35844135 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | AKAP8 GPATCH1 INTS1 NSD1 DIDO1 CHD4 ZBTB7B HNRNPAB HNRNPK STT3B ESYT2 MDN1 ZBED4 BAZ2A ZNF638 IK TASOR MNT | 3.54e-06 | 1294 | 137 | 18 | 30804502 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | AKAP8 IPO7 INTS1 PSMD3 CHD4 HNRNPAB HNRNPK NF1 MDN1 ZNF638 SMARCC2 IK | 3.59e-06 | 582 | 137 | 12 | 20467437 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 3.70e-06 | 104 | 137 | 6 | 31240132 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLNA GPATCH1 NASP DIDO1 CHD4 CBS HNRNPAB HNRNPK KIAA1671 BAZ2A FAM169A ZNF638 SENP6 TASOR DCP1A | 4.51e-06 | 934 | 137 | 15 | 33916271 |
| Pubmed | 4.94e-06 | 9 | 137 | 3 | 16382099 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 IPO7 INTS1 NSD1 NASP DIDO1 CHD4 BAZ2A FAM169A SENP6 SMARCC2 DOT1L | 5.59e-06 | 608 | 137 | 12 | 36089195 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.64e-06 | 410 | 137 | 10 | 26949251 | |
| Pubmed | CACNA1B FLNA PPP1R12B NOL6 NSD1 PODXL2 KIAA1671 VPS52 PRKAB1 MAPK7 ZNF333 MNT DKKL1 ZNF646 | 5.65e-06 | 832 | 137 | 14 | 36724073 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | SALL3 PSMD3 CHD4 HNRNPAB NDEL1 HNRNPUL2 BAZ2A ZNF638 SMARCC2 IK | 5.76e-06 | 411 | 137 | 10 | 35182466 |
| Pubmed | 6.75e-06 | 329 | 137 | 9 | 17474147 | ||
| Pubmed | 8.78e-06 | 340 | 137 | 9 | 24332808 | ||
| Pubmed | AKAP6 PDE9A PPRC1 PEG3 ZBTB4 MCF2L2 NASP CHD4 JAKMIP3 USP9Y WRAP53 CBS HNRNPK FAM120A CCN1 MICAL2 SENP6 | 1.29e-05 | 1285 | 137 | 17 | 35914814 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNA IPO7 NOL6 NASP PSMD3 CHD4 CBS HNRNPAB TSFM HNRNPK STT3B POLR3A NF1 MDN1 FAM120A HNRNPUL2 PEAK1 IK | 1.32e-05 | 1425 | 137 | 18 | 30948266 |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.38e-05 | 37 | 137 | 4 | 25798587 | |
| Pubmed | CACNA1A FLNA PPP1R12B PSMD3 HNRNPAB HNRNPK NF1 NDEL1 FAM120A SHANK2 ARVCF HNRNPUL2 MICAL2 SMARCC2 PEAK1 DMD PRKAG2 TNNT2 | 1.39e-05 | 1431 | 137 | 18 | 37142655 | |
| Pubmed | 1.39e-05 | 274 | 137 | 8 | 34244482 | ||
| Pubmed | Hundreds of variants clustered in genomic loci and biological pathways affect human height. | 1.44e-05 | 198 | 137 | 7 | 20881960 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.54e-05 | 2 | 137 | 2 | 23426690 | |
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23376566 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 23796711 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 38155373 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 18253029 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 30472186 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 24755485 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 20547676 | ||
| Pubmed | 1.54e-05 | 2 | 137 | 2 | 15050706 | ||
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 1.57e-05 | 79 | 137 | 5 | 26446488 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | FLNA ARHGEF16 HNRNPK KIAA1671 ESYT2 SH3PXD2B SHANK2 ARVCF VSIG10L PALM3 PEAK1 | 1.58e-05 | 565 | 137 | 11 | 25468996 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FLNA NOL6 INTS1 NASP DIDO1 PSMD3 CHD4 WRAP53 HNRNPAB TSFM HNRNPK ESYT2 VPS52 MDN1 FAM120A HNRNPUL2 BAZ2A | 1.79e-05 | 1318 | 137 | 17 | 30463901 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | FLNA IRF2BP1 NOL6 INTS1 CHD4 HNRNPK POLR3A ZBED4 BAZ2A IK ZNF646 | 2.11e-05 | 583 | 137 | 11 | 29844126 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | AKAP8 INTS1 DIDO1 PODXL2 CHD4 USP9Y HNRNPAB HNRNPK STT3B ZBED4 HNRNPUL2 ZNF638 SMARCC2 IK MED12 | 2.54e-05 | 1082 | 137 | 15 | 38697112 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | AKAP8 NOL6 CHD4 HNRNPAB HNRNPK MDN1 FAM120A HNRNPUL2 ZNF638 SMARCC2 IK | 2.96e-05 | 605 | 137 | 11 | 28977666 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNA SETD1B PPRC1 ZBTB4 INTS1 NSD1 WRAP53 SH3PXD2B MDN1 SHANK2 ZBED4 ARVCF DOT1L MED12 RAB11FIP3 | 3.23e-05 | 1105 | 137 | 15 | 35748872 |
| Pubmed | 3.26e-05 | 225 | 137 | 7 | 31478661 | ||
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 3.35e-05 | 226 | 137 | 7 | 25900982 | |
| Pubmed | FLNA IPO7 PPP1R12B PSMD3 CHD4 HNRNPK FAM120A CCN1 ARVCF MICAL2 SMARCC2 PRKCZ DOT1L IK MED12 DCP1A | 3.42e-05 | 1247 | 137 | 16 | 27684187 | |
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 3.88e-05 | 157 | 137 | 6 | 30686591 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | PDE9A EFS PPP1R12B ZBTB7B BLZF1 HELQ HNRNPK VPS52 CLCN2 DMD MAPK7 DCP1A | 3.99e-05 | 742 | 137 | 12 | 26871637 |
| Pubmed | 4.18e-05 | 234 | 137 | 7 | 36243803 | ||
| Pubmed | 4.40e-05 | 322 | 137 | 8 | 26514267 | ||
| Pubmed | CACNA1A CACNA1B FLNA RER1 PSMD3 HNRNPAB STT3B ESYT2 NF1 SHANK2 HNRNPUL2 SNX25 FAM169A SMARCC2 PEAK1 | 4.56e-05 | 1139 | 137 | 15 | 36417873 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 20200162 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 29466725 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 38996073 | ||
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 30425165 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.61e-05 | 3 | 137 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.61e-05 | 3 | 137 | 2 | 26507659 | |
| Pubmed | 4.61e-05 | 3 | 137 | 2 | 31857666 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 4.61e-05 | 3 | 137 | 2 | 24394417 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.61e-05 | 3 | 137 | 2 | 24523520 | |
| Pubmed | IPO7 IRF2BP1 NOL6 PRDM5 IL1RAPL1 NF1 MDN1 ARVCF ASXL3 SMARCC2 TMED2 | 4.78e-05 | 638 | 137 | 11 | 31182584 | |
| Pubmed | IPO7 IRF2BP1 TCEAL4 INTS1 RNF213 DIDO1 PSMD3 CHD4 POLR3A MDN1 HNRNPUL2 SMARCC2 IK MED12 | 5.01e-05 | 1014 | 137 | 14 | 32416067 | |
| Pubmed | 5.22e-05 | 330 | 137 | 8 | 32529326 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 5.45e-05 | 332 | 137 | 8 | 32786267 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 5.48e-05 | 167 | 137 | 6 | 20362541 | |
| Pubmed | FLNA NOL6 INTS1 DIDO1 CHD4 HNRNPAB HNRNPK HNRNPUL2 ZNF638 SMARCC2 TMED2 | 5.80e-05 | 652 | 137 | 11 | 31180492 | |
| Pubmed | FLNA PSD2 AKAP8 IPO7 NASP PSMD3 WRAP53 HNRNPK STT3B ESYT2 IK | 5.88e-05 | 653 | 137 | 11 | 33742100 | |
| Pubmed | 5.93e-05 | 104 | 137 | 5 | 9205841 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 6.98e-05 | 344 | 137 | 8 | 30333137 | |
| Pubmed | FLNA AKAP8 PSMD3 HNRNPAB HNRNPK FAM120A HNRNPUL2 MAPK6 IK TASOR | 6.98e-05 | 551 | 137 | 10 | 34728620 | |
| Pubmed | 7.27e-05 | 346 | 137 | 8 | 25324306 | ||
| Pubmed | 7.42e-05 | 347 | 137 | 8 | 16033648 | ||
| Pubmed | 7.55e-05 | 21 | 137 | 3 | 25340873 | ||
| Pubmed | 7.56e-05 | 177 | 137 | 6 | 26206133 | ||
| Pubmed | BNC2 SALL3 BACH2 PEG3 DIDO1 PRDM5 ZBTB7B ZBED4 BAZ2A ZNF638 MNT ZNF646 | 8.96e-05 | 808 | 137 | 12 | 20412781 | |
| Pubmed | FLNA IPO7 NASP CHD4 CBS HNRNPAB HNRNPK ESYT2 MDN1 FAM120A BAZ2A DMD | 9.06e-05 | 809 | 137 | 12 | 32129710 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | PODXL ARHGEF16 STT3B ESYT2 NF1 CLCN2 ARVCF MICAL2 GCC1 PEAK1 | 9.10e-05 | 569 | 137 | 10 | 30639242 |
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 31800012 | ||
| Pubmed | 9.19e-05 | 4 | 137 | 2 | 22232556 | ||
| Pubmed | PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5. | 9.19e-05 | 4 | 137 | 2 | 20538799 | |
| Pubmed | Non-catalytic beta- and gamma-subunit isoforms of the 5'-AMP-activated protein kinase. | 9.19e-05 | 4 | 137 | 2 | 8621499 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 9.19e-05 | 4 | 137 | 2 | 25483588 | |
| Pubmed | The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. | 9.19e-05 | 4 | 137 | 2 | 16177794 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 9.19e-05 | 4 | 137 | 2 | 37141091 | |
| Interaction | MEN1 interactions | ERCC6 SETD1B AKAP8 GPATCH1 NOL6 INTS1 RNF213 DIDO1 CHD4 FOXN3 CBS HNRNPAB MDN1 FAM120A BAZ2A ZNF638 SMARCC2 DOT1L IK TASOR MED12 DCP1A | 1.49e-06 | 1029 | 136 | 22 | int:MEN1 |
| Interaction | SNRNP40 interactions | FLNA AKAP8 GPATCH1 NOL6 ZBTB4 GON4L ZBTB7B HNRNPAB HNRNPUL2 BAZ2A SENP6 SMARCC2 DOT1L IK TASOR MED12 | 6.40e-06 | 637 | 136 | 16 | int:SNRNP40 |
| Interaction | CDC5L interactions | AKAP6 AKAP8 IPO7 GPATCH1 INTS1 PSMD3 CHD4 HNRNPK VPS52 NF1 MDN1 HNRNPUL2 ZNF638 SENP6 SMARCC2 DOT1L IK CDC25B | 1.82e-05 | 855 | 136 | 18 | int:CDC5L |
| GeneFamily | Calcium voltage-gated channel subunits | 2.58e-04 | 26 | 87 | 3 | 253 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.78e-04 | 34 | 87 | 3 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF597 BNC2 ZFAT SALL3 ZNF862 PEG3 ZBTB4 PRDM5 ZBTB7B ZNF333 ZNF646 | 6.44e-04 | 718 | 87 | 11 | 28 |
| GeneFamily | PHD finger proteins | 9.33e-04 | 90 | 87 | 4 | 88 | |
| GeneFamily | Mitogen-activated protein kinases | 1.72e-03 | 13 | 87 | 2 | 651 | |
| GeneFamily | RNA binding motif containing | 3.66e-03 | 213 | 87 | 5 | 725 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.59e-06 | 166 | 136 | 8 | M39026 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_UP | 6.13e-06 | 50 | 136 | 5 | M847 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_C_UP | 6.13e-06 | 50 | 136 | 5 | MM789 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_UP | 9.49e-06 | 198 | 136 | 8 | M10031 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | CACNA1A CACNA1B PODXL2 MDN1 AGO4 SHANK2 BAZ2A DOT1L GOLGA8A UNC79 | 3.74e-05 | 389 | 136 | 10 | M39102 |
| Coexpression | GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 4.60e-05 | 181 | 136 | 7 | M6849 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-06 | 176 | 137 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.15e-06 | 191 | 137 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.38e-06 | 194 | 137 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.38e-06 | 194 | 137 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.91e-06 | 200 | 137 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-06 | 157 | 137 | 6 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 176 | 137 | 6 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 182 | 137 | 6 | dfde2d9950f445c6c936ac828f7210de87bb45ec | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-05 | 182 | 137 | 6 | 52274af3136d4fd4a495f5882618444661421f0f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.20e-05 | 183 | 137 | 6 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 185 | 137 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.57e-05 | 188 | 137 | 6 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.57e-05 | 188 | 137 | 6 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.64e-05 | 189 | 137 | 6 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.64e-05 | 189 | 137 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 189 | 137 | 6 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.64e-05 | 189 | 137 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.72e-05 | 190 | 137 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.72e-05 | 190 | 137 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 190 | 137 | 6 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-05 | 190 | 137 | 6 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.72e-05 | 190 | 137 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.80e-05 | 191 | 137 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 3.06e-05 | 194 | 137 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 194 | 137 | 6 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.15e-05 | 195 | 137 | 6 | dba2a87efd7e067c094c4b367feb4138cab62735 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 195 | 137 | 6 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 195 | 137 | 6 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.24e-05 | 196 | 137 | 6 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 196 | 137 | 6 | 1d94cecd378a829dd8014fc086d7fca48c953a91 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 196 | 137 | 6 | aacec48285bcb7ccf1b538187071885e3602cc49 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-05 | 197 | 137 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-05 | 198 | 137 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.43e-05 | 198 | 137 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 3.50e-05 | 120 | 137 | 5 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 137 | 6 | 9a08c25bb4851ad4ac9db8916422280f71378c2c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.53e-05 | 199 | 137 | 6 | a207b4891881149d4c50721310690fd794157723 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-05 | 199 | 137 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-05 | 199 | 137 | 6 | 2ed10c5e15c9d5ed0a8bea580842348d5698a07b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 02cae2c296a13ad4cbb53bca7a86d64629d67d66 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 3.63e-05 | 200 | 137 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.79e-05 | 122 | 137 | 5 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.13e-05 | 130 | 137 | 5 | a3e12984fb61311e49cc76c59f74f4dffc48faa1 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.34e-05 | 144 | 137 | 5 | 5e948d4cb913ccd8f82262a1b4d20967aadab3ab | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.61e-05 | 145 | 137 | 5 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-04 | 153 | 137 | 5 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.11e-04 | 153 | 137 | 5 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.14e-04 | 154 | 137 | 5 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 1.21e-04 | 156 | 137 | 5 | 01f2c0c6a936dfb59bc727feef428a906ad2a80b | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 158 | 137 | 5 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 161 | 137 | 5 | 5a8698790f9aba796dd2b64af419055c60bd7de8 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type | 1.45e-04 | 162 | 137 | 5 | 1afeeb17e263cf625a4f285203cf82f973735193 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.62e-04 | 166 | 137 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 169 | 137 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 173 | 137 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 174 | 137 | 5 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 174 | 137 | 5 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 174 | 137 | 5 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.08e-04 | 175 | 137 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.08e-04 | 175 | 137 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.19e-04 | 177 | 137 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 177 | 137 | 5 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.36e-04 | 180 | 137 | 5 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 137 | 5 | 35c73670da90cb6924e822a2426d13a675685f09 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 181 | 137 | 5 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 181 | 137 | 5 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 2.43e-04 | 181 | 137 | 5 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 182 | 137 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 182 | 137 | 5 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 182 | 137 | 5 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-04 | 182 | 137 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.55e-04 | 183 | 137 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-04 | 183 | 137 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.55e-04 | 183 | 137 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 184 | 137 | 5 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.62e-04 | 184 | 137 | 5 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.62e-04 | 184 | 137 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-04 | 184 | 137 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Unfolded_protein_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.67e-04 | 101 | 137 | 4 | ae650e96b93a0d2f0a19ffaf37f21f02fb20651d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.68e-04 | 185 | 137 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-04 | 185 | 137 | 5 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.68e-04 | 185 | 137 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.75e-04 | 186 | 137 | 5 | 76cbc3610aedf8c19c17ad5faf6ef5e8980b6af5 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-04 | 186 | 137 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.75e-04 | 186 | 137 | 5 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.75e-04 | 186 | 137 | 5 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 187 | 137 | 5 | 689b3cc76f1e04bd35a7d3ce19e9f08744a7835b | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.82e-04 | 187 | 137 | 5 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.82e-04 | 187 | 137 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 187 | 137 | 5 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 187 | 137 | 5 | 3912bbb610a4a84791e9bda92a2d57a52c31d29e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 187 | 137 | 5 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.89e-04 | 188 | 137 | 5 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.89e-04 | 188 | 137 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.11e-07 | 166 | 136 | 9 | 7324_DN | |
| Drug | troglitazone; Down 200; 10uM; HL60; HT_HG-U133A | 2.09e-06 | 189 | 136 | 9 | 2692_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.59e-06 | 194 | 136 | 9 | 2295_DN | |
| Drug | 3,4-dihydroquinazoline | 4.12e-06 | 6 | 136 | 3 | CID000583065 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.73e-06 | 173 | 136 | 8 | 2084_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.10e-05 | 176 | 136 | 8 | 6784_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 136 | 8 | 2232_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; PC3; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 7292_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.49e-05 | 197 | 136 | 8 | 2812_UP | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 2.78e-05 | 200 | 136 | 8 | 2481_UP | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.78e-05 | 200 | 136 | 8 | 5634_UP | |
| Drug | IAA-94 | 3.21e-05 | 61 | 136 | 5 | CID000003667 | |
| Drug | leys | 3.32e-05 | 11 | 136 | 3 | CID000484683 | |
| Drug | fenipentol | 4.41e-05 | 12 | 136 | 3 | CID000003338 | |
| Drug | AC1L2VU3 | 4.41e-05 | 12 | 136 | 3 | CID000129572 | |
| Disease | Intellectual Disability | AKAP6 CACNA1B NSD1 GON4L HNRNPK STT3B SHROOM4 NF1 SHANK2 SMARCC2 CACNA1G VPS53 | 9.27e-07 | 447 | 133 | 12 | C3714756 |
| Disease | FG syndrome (is_implicated_in) | 6.03e-05 | 3 | 133 | 2 | DOID:14711 (is_implicated_in) | |
| Disease | FG SYNDROME 4 (disorder) | 6.03e-05 | 3 | 133 | 2 | C1845546 | |
| Disease | FG SYNDROME 2 | 6.03e-05 | 3 | 133 | 2 | C1845902 | |
| Disease | FG SYNDROME 3 | 6.03e-05 | 3 | 133 | 2 | C1845567 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 6.03e-05 | 3 | 133 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | FG syndrome | 6.03e-05 | 3 | 133 | 2 | C0220769 | |
| Disease | FG syndrome | 1.20e-04 | 4 | 133 | 2 | cv:C0220769 | |
| Disease | migraine (implicated_via_orthology) | 1.20e-04 | 4 | 133 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Malignant Cystosarcoma Phyllodes | 2.00e-04 | 5 | 133 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 2.00e-04 | 5 | 133 | 2 | C0010701 | |
| Disease | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | 2.99e-04 | 6 | 133 | 2 | C3888239 | |
| Disease | Global developmental delay | 3.50e-04 | 133 | 133 | 5 | C0557874 | |
| Disease | Colorectal Carcinoma | AKAP6 ERCC6 SALL3 EFS PEG3 MCF2L2 ABCA10 NF1 PRKCZ DMD SPAG17 | 3.50e-04 | 702 | 133 | 11 | C0009402 |
| Disease | Mental Retardation, X-Linked 1 | 4.04e-04 | 32 | 133 | 3 | C2931498 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 4.17e-04 | 7 | 133 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 4.28e-04 | 139 | 133 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.28e-04 | 139 | 133 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.28e-04 | 139 | 133 | 5 | C0917816 | |
| Disease | body weight | AKAP6 CACNA1B ZFAT DPY19L2 TCEAL4 DAB2 GON4L PRDM5 SH3PXD2B ASXL3 ZNF638 SENP6 DMD DOT1L UNC79 | 5.77e-04 | 1261 | 133 | 15 | EFO_0004338 |
| Disease | Schizophrenia and related disorders | 7.11e-04 | 9 | 133 | 2 | C0809983 | |
| Disease | Craniofacial Abnormalities | 7.23e-04 | 156 | 133 | 5 | C0376634 | |
| Disease | Malignant neoplasm of breast | AKAP6 FLNA ERCC6 AKAP8 PPP1R12B MCF2L2 JAKMIP3 HELQ HNRNPK NF1 DMD MED12 ZNF646 | 1.16e-03 | 1074 | 133 | 13 | C0006142 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.78e-03 | 53 | 133 | 3 | C4707243 | |
| Disease | age at menopause | 2.53e-03 | 302 | 133 | 6 | EFO_0004704 | |
| Disease | erythritol measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0021171 | |
| Disease | Moyamoya Disease | 2.62e-03 | 17 | 133 | 2 | C0026654 | |
| Disease | verbal-numerical reasoning measurement | 2.97e-03 | 131 | 133 | 4 | EFO_0008394 | |
| Disease | cortical surface area measurement | CACNA1A BNC2 EFS PODXL PPP1R12B PRDM5 AFAP1L1 NDEL1 CLCN2 FAM13A PRKCZ MAPK6 PRKAG2 SPAG17 | 3.06e-03 | 1345 | 133 | 14 | EFO_0010736 |
| Disease | ovarian carcinoma | 3.42e-03 | 321 | 133 | 6 | EFO_0001075 | |
| Disease | otitis media (implicated_via_orthology) | 4.39e-03 | 22 | 133 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | triacylglycerol 48:2 measurement | 4.39e-03 | 22 | 133 | 2 | EFO_0010405 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 4.39e-03 | 22 | 133 | 2 | cv:C0949658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPDDDKTPMSERLDD | 121 | O00555 | |
| IDLEDTGPMEDTASK | 951 | Q5RHP9 | |
| AEEETKAPPNEMGSD | 1111 | Q5RHP9 | |
| EDPDKDDFLGSLMID | 461 | A0FGR8 | |
| GPAEAGMLEKLEFED | 236 | Q9UGJ0 | |
| DEPDAKDRAGDVEMD | 296 | Q9BYV9 | |
| EGEKTGSRDVIPMDA | 881 | O00192 | |
| IGTPDEETMDIELPK | 16 | Q8WWZ4 | |
| KGEDPFTSETVDPEM | 541 | O43823 | |
| SESSEPKLGEESMEG | 726 | Q6ZN30 | |
| GIDDTELMGAEDKLP | 316 | Q9UIF9 | |
| ELMGAEDKLPLEDSP | 321 | Q9UIF9 | |
| DSIKDPMEDQDGLLG | 166 | O00622 | |
| PAPSFSLDDMDVDKD | 126 | Q5VV41 | |
| KPVGFGEKSDEDELM | 111 | P59074 | |
| TRKMEEEPLGPDLED | 471 | P11532 | |
| PMDSGAEEEKAGAAT | 371 | Q8TEK3 | |
| DRVDMEVTLPGEGKD | 101 | Q9HCK5 | |
| GLDSEEMERLPGDAS | 236 | Q9NPI6 | |
| GDKTPMSERLDDTEP | 121 | Q00975 | |
| ESDMRPEAEGDSEGE | 356 | Q03468 | |
| DKGFRMDTEDFPGPE | 1676 | Q9C0F0 | |
| PKETVEEGVEHDPGM | 1511 | Q96L73 | |
| SPELMEGPEEDIADK | 451 | O75154 | |
| GPFAGEKRMPEDLDE | 36 | Q9NQX1 | |
| SEEKPGTGRDEAEMS | 406 | A6NDB9 | |
| EEPMDKVEEGPLSFL | 181 | Q8NG50 | |
| ESDMRPEAEGDSEGE | 356 | P0DP91 | |
| LMGGKRDPEDSDVFE | 586 | Q9NZ53 | |
| GIDDVPDARGDKMSQ | 56 | P98082 | |
| MAEPLKEEDGEDGSA | 1 | Q13164 | |
| SDMKLGDQGPPEEAE | 441 | O00592 | |
| LPKEFMEDSAGEGAT | 4656 | Q9NU22 | |
| EDNKTEETGPGMDEE | 4791 | Q9NU22 | |
| VLPSSMDKDERSDEP | 1771 | Q9BY89 | |
| GDGMETEEPPKSVEV | 21 | Q9H2G9 | |
| GSLRDGEEKEPPMEE | 1001 | Q8N201 | |
| GEEKEPPMEEDVGDT | 1006 | Q8N201 | |
| DKGPSDAEVVDEISM | 601 | P56696 | |
| EGSFEGDLKVPRMEE | 131 | Q9UK85 | |
| EDMEIDPGELGGSAK | 776 | Q86YR7 | |
| LDDEPGGEAETKMLS | 271 | P43897 | |
| KSVLGPEDFMDEEDL | 86 | Q9BRR8 | |
| PDEEGSDDKAVTAMG | 596 | O95373 | |
| EEPIAFDGSRMSKEE | 86 | Q9NZN1 | |
| MLETEPVEDGKLGER | 641 | Q16659 | |
| EREDGKEDISDPMDP | 1086 | Q9H792 | |
| EKSEGLPVAPFMDRD | 491 | O76083 | |
| KGLEEPEMDPKSRDL | 496 | Q1KMD3 | |
| EPEVMEPALEGTGKE | 16 | Q9H6R4 | |
| TPCTPDDDLEEGMAK | 481 | Q5VZ66 | |
| EDMEEDRAGLGPPKL | 341 | Q99583 | |
| ESDLKDDDAVPPGME | 276 | P30305 | |
| KLEDPGLSESMDIDP | 656 | Q93074 | |
| LDTEGLGDMEKSDPK | 96 | Q8N8V2 | |
| APMDVGEEPLEKAAR | 51 | P22413 | |
| DGSLAENGVMAEEKP | 1046 | Q9NZB2 | |
| PKPDMITRLEGEEES | 91 | Q9P215 | |
| PEVEEEMEKSALGGG | 31 | Q6NUT2 | |
| EDDADGFISPMDDKI | 916 | O94988 | |
| GGREDMDISKSAEEP | 181 | P49321 | |
| GSDMEDPQKDDPDDK | 1091 | Q9GZU2 | |
| EGEAVMPPLEDDDKF | 711 | Q6ZMV5 | |
| MVKEDREATEGTGNP | 26 | Q8IZS5 | |
| FEDMDLNKDGEVPPE | 506 | Q96AY3 | |
| DLEIMPSSEAADGEK | 461 | Q96CN9 | |
| QDSKPDKDMEASEPG | 161 | Q8WV48 | |
| GEVELADREMPDSDS | 676 | O43497 | |
| AEMPATEKDLAEDAP | 26 | P21333 | |
| DGEMDPKVPAIEENL | 206 | Q53ET0 | |
| PESDDEEMKEAAGSL | 446 | O00409 | |
| KMEPEEAREEISGSP | 1326 | Q3T8J9 | |
| MIEDAERDGTLKPGD | 126 | P35520 | |
| MDDKGDPSNEEAPKA | 1 | Q9BTC0 | |
| KVEGDPEGREMEDDP | 351 | O43281 | |
| QDGEKESELEPMNGE | 416 | Q9Y6X4 | |
| PGDEGKEEEEMVAEN | 36 | Q8TDG4 | |
| RTEEPMETEPKGAAD | 1626 | Q14839 | |
| EGEARPVEKEAEPMD | 121 | Q9BXA9 | |
| PEEEDKATAAEMAVP | 281 | Q5VV67 | |
| EKAASEPEAGAMPEK | 11 | Q5VZR4 | |
| EKAASEPEAGAMPEK | 11 | Q5SR56 | |
| EPEGEAAGKMTTEEQ | 386 | Q8IU81 | |
| GEDGLSDPAEMTSDE | 1361 | O94851 | |
| ADSMEAKGVEEPGGD | 726 | Q7Z6I6 | |
| MLPVDGEERKSEGSD | 1 | A7E2F4 | |
| DMEEPSSGPRKEIED | 76 | A6NKG5 | |
| KVDPSLMEDSDDGPS | 86 | O15258 | |
| EFGEIEAIELPMDPK | 176 | Q99729 | |
| GKAMEDTSGEPAAED | 126 | Q9BUR4 | |
| KDEMGPRDEAGEEAV | 416 | Q9H3E2 | |
| NGEFGKRPAEDMEEE | 16 | P61978 | |
| GLDPAAMEGKDEPLE | 906 | O14802 | |
| KDQPEMAEIGLGEEE | 1291 | Q9ULL8 | |
| DLVGDRTPTSEKMDE | 616 | Q9UPS6 | |
| EDTEPSDSGDEMMDP | 56 | Q9NXX6 | |
| PVKGGTMTDLDEQED | 371 | Q8TAQ2 | |
| NPGLELMEKEVEPEG | 21 | O43868 | |
| DDELEEMLESGKPSI | 161 | P32856 | |
| GMAPEDKDPDLETIL | 1141 | Q6Q759 | |
| EDEKAEVEMKPDSSP | 1331 | Q9UPX8 | |
| GGGDDEMKQALPELE | 21 | Q9UK61 | |
| GDRPKILMDSPEDAD | 31 | Q9Y478 | |
| TPTVEQGEGEEAMKD | 31 | Q13023 | |
| SDLRDMPEDDGEPSK | 81 | Q8TED9 | |
| DKDSMPDGNLSEEEK | 86 | Q9BWW9 | |
| LASDADLEGEMSPEE | 756 | P51788 | |
| DFLSEPEGGPEMAKE | 4241 | Q63HN8 | |
| ESEMEGGSEREGKPE | 81 | Q96EI5 | |
| LRAGTSDMEEEEGPL | 16 | Q8N1B4 | |
| MLGLQEEAPAEKPEE | 231 | O75312 | |
| QLEEGRKEPEAPGEM | 541 | Q9P243 | |
| SMADGDLEPEEGSKT | 821 | Q5TCY1 | |
| EELGSDEDAIDPDLM | 301 | O15156 | |
| ELIGAMLEPTDEEPK | 21 | Q96GT9 | |
| APQDVEMKEEAATGG | 31 | O43242 | |
| IMPKKPAEEGNDSEE | 111 | Q16385 | |
| MEEDKLLSAVPEEGD | 1 | Q9BQI7 | |
| DDMKRENPPVEDSSD | 486 | Q8TCJ2 | |
| AGYEEISDPDMEEKP | 506 | A1X283 | |
| EGDILKPEEETMEFP | 431 | Q86VQ3 | |
| EAKEAEDGPMEESKP | 61 | P45379 | |
| AQMEEARDPKAGTGE | 1616 | O15015 | |
| MLSVEEEGKEDPLPT | 576 | P28908 | |
| TDLRPGELSGEEMEE | 621 | Q9P1Z0 | |
| QPEEGDGVELMEAKS | 1086 | P21359 | |
| SDESPEAGKMLEDEL | 916 | Q9GZR1 | |
| DEPMDVDKGPGSTKE | 391 | Q13123 | |
| MGDEPDLDPDINKDF | 706 | O00507 | |
| TPEMEELATEKGDLD | 391 | Q5VIR6 | |
| PELTGELGDDDRKGM | 51 | Q6ZVL8 | |
| MEPRESGKAPVTFDD | 1 | O60290 | |
| QEDKVEEEAMAPGLP | 181 | Q96JL9 | |
| DIGEAPKGQDMETEA | 111 | Q15363 | |
| MTDSDEDALKVDQGP | 1 | Q8NEE8 | |
| SLEDAALMGEEGKPE | 46 | Q96LX8 | |
| VEAPDSKFSPDDMDL | 156 | Q86VR7 | |
| SMPVKTRAEGEDDGF | 46 | Q8N1Y9 | |
| AGGIESREDPLMSED | 556 | Q9H347 | |
| MSEVDEESGLKDSEP | 1881 | Q14966 | |
| TLEDPMDAEGSSKPE | 1716 | Q9P2D8 | |
| MDAEGSSKPEELPEF | 1721 | Q9P2D8 | |
| GIPPDSLERMDFKSE | 31 | O75132 | |
| DDSEDLKPVIDGMDG | 226 | Q05513 | |
| EGEVPSDLAEEPAMK | 156 | O60237 | |
| MDGEDIPDFSSLKEE | 1 | Q9GZM8 |